Cost-effectiveness of multidimensional family therapy compared to cognitive behavioral therapy for adolescents with a cannabis use disorder: Data from a randomized controlled trial

被引:18
|
作者
Goorden, M. [1 ,2 ]
van der Schee, E. [3 ]
Hendriks, V. M. [3 ,4 ]
Hakkaart-van Roijena, L. [1 ,2 ]
机构
[1] Erasmus Univ, Inst Med Technol Assessment, POB 1738, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus Univ, Inst Hlth Policy & Management, POB 1738, NL-3000 DR Rotterdam, Netherlands
[3] Parnassia Grp, Brijder Addict Treatment, PARC, POB 53002, The Hague, Netherlands
[4] Leiden Univ, Dept Child & Adolescent Psychiat, Med Ctr, Curium, POB 37, NL-2300 AA Leiden, Netherlands
关键词
Cost-effectiveness; MDFT; CBT; Cannabis use disorder; Adolescents; Delinquency; ISRCTN00179361; SUBSTANCE-ABUSE; MAIN FINDINGS; VALIDITY;
D O I
10.1016/j.drugalcdep.2016.03.004
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: To evaluate the cost-effectiveness of Multidimensional Family Therapy (MDFT) for adolescents with a cannabis use disorder, compared to Cognitive Behavioural Therapy (CBT). Methods: A parallel-group randomized controlled trial was performed. 109 adolescents with a DSM-IV cannabis use disorder (CBT n = 54; MDFT n = 55) were included. Assessments were conducted at baseline, and 3, 6, 9 and 12 months post-baseline, and included measures on cannabis and other substance use, delinquency, health care utilization, and general health related quality of life. Results: Excluding those with missing cost-data, 96 participants (MDFT n=49; CBT n=47) were included. From a health care perspective, the average annual direct medical costs in the CBT group were 2015 (95% C.I. 1397-2714), compared to (sic)5446 (95% CI. 4159-7092) in the MDFT group. The average quality adjusted life years (QALY's) gained were 0.06 QALY higher for the MDFT group, which led to an incremental cost-effectiveness ratio (ICER) of 54,308 Euro/QALY or (sic)43,405 per recovered patient. Taking the costs of delinquency into account, the costs increased to (sic)21,330 (95% C.I. 12,389-32,894) for the CBT group and to (sic)21,915 (95% C.I. 16,273-28,181) for the MDFT group, which lead to an ICER of 9266 Euro/QALY or a cost per recovered patient of (sic)7491. Conclusions: This is the first comprehensive CEA of MDFT compared to CBT and it demonstrated that when costs of delinquency were included, the ICERS were modest. The results underline the importance of adopting a broader perspective regarding cost effectiveness analyses in mental health care. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:154 / 161
页数:8
相关论文
共 50 条
  • [1] Cost-Effectiveness of Multidimensional Family Therapy for Adolescents with a Cannabis Use Disorder
    Goorden, M.
    van der Schee, E.
    Hendriks, V. M.
    Roijen, L. Haldcaart-van
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2015, 18 : S17 - S17
  • [2] Matching adolescents with a cannabis use disorder to multidimensional family therapy or cognitive behavioral therapy: Treatment effect moderators in a randomized controlled trial
    Hendriks, Vincent
    van der Schee, Evelien
    Blanken, Peter
    DRUG AND ALCOHOL DEPENDENCE, 2012, 125 (1-2) : 119 - 126
  • [3] Treatment of adolescents with a cannabis use disorder: Main findings of a randomized controlled trial comparing multidimensional family therapy and cognitive behavioral therapy in The Netherlands
    Hendriks, Vincent
    van der Schee, Evelien
    Blanken, Peter
    DRUG AND ALCOHOL DEPENDENCE, 2011, 119 (1-2) : 64 - 71
  • [4] Cost-Effectiveness of Group and Internet Cognitive Behavioral Therapy for Insomnia in Adolescents: Results from a Randomized Controlled Trial
    De Bruin, Eduard J.
    van Steensel, Francisca J. A.
    Meijer, Anne Marie
    SLEEP, 2016, 39 (08) : 1571 - 1581
  • [5] Multidimensional family therapy in adolescents with a cannabis use disorder: long-term effects on delinquency in a randomized controlled trial
    Thimo M. van der Pol
    Vincent Hendriks
    Henk Rigter
    Moran D. Cohn
    Theo A. H. Doreleijers
    Lieke van Domburgh
    Robert R. J. M. Vermeiren
    Child and Adolescent Psychiatry and Mental Health, 12
  • [6] Multidimensional family therapy in adolescents with a cannabis use disorder: long-term effects on delinquency in a randomized controlled trial
    van der Pol, Thimo M.
    Hendriks, Vincent
    Rigter, Henk
    Cohn, Moran D.
    Doreleijers, Theo A. H.
    van Domburgh, Lieke
    Vermeiren, Robert R. J. M.
    CHILD AND ADOLESCENT PSYCHIATRY AND MENTAL HEALTH, 2018, 12
  • [7] Cost-effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: Analysis of a randomized controlled trial
    Watanabe, Norio
    Furukawa, Toshiaki A.
    Shimodera, Shinji
    Katsuki, Fujika
    Fujita, Hirokazu
    Sasaki, Megumi
    Sado, Mitsuhiro
    Perlis, Michael L.
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2015, 69 (06) : 335 - 343
  • [8] INCANT: a transnational randomized trial of Multidimensional Family Therapy versus treatment as usual for adolescents with cannabis use disorder
    Henk Rigter
    Isidore Pelc
    Peter Tossmann
    Olivier Phan
    Esther Grichting
    Vincent Hendriks
    Cindy Rowe
    BMC Psychiatry, 10
  • [9] INCANT: a transnational randomized trial of Multidimensional Family Therapy versus treatment as usual for adolescents with cannabis use disorder
    Rigter, Henk
    Pelc, Isidore
    Tossmann, Peter
    Phan, Olivier
    Grichting, Esther
    Hendriks, Vincent
    Rowe, Cindy
    BMC PSYCHIATRY, 2010, 10
  • [10] Cost-effectiveness of Internet-based cognitive behavior therapy vs. cognitive behavioral group therapy for social anxiety disorder: Results from a randomized controlled trial
    Hedman, Erik
    Andersson, Erik
    Ljotsson, Brjann
    Andersson, Gerhard
    Ruck, Christian
    Lindefors, Nils
    BEHAVIOUR RESEARCH AND THERAPY, 2011, 49 (11) : 729 - 736